Business Coach
9562
Artra Group
6029
D. Western Therapeutics Institute
4576
Daiwa Cycle
5888
Liberta
4935
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.53%658.93M | 17.51%648.54M | 6.15%2.32B | 8.44%605.54M | 10.48%577.45M | 2.07%580.38M | 3.84%551.9M | 13.05%2.18B | 7.18%558.44M | 5.35%522.66M |
Cost of revenue | 26.46%232.35M | 20.43%213.82M | -0.09%725.42M | 9.29%185.78M | 6.20%178.36M | -13.97%183.73M | 1.70%177.55M | 16.62%726.05M | 5.10%169.98M | 5.00%167.94M |
Gross profit | 7.55%426.58M | 16.13%434.72M | 9.26%1.59B | 8.06%419.77M | 12.51%399.09M | 11.71%396.65M | 4.89%374.35M | 11.35%1.46B | 8.12%388.46M | 5.52%354.72M |
Operating expense | 4.61%268.29M | 17.63%288.05M | 6.73%997.39M | 6.54%255.46M | 7.00%240.6M | 11.09%256.46M | 2.45%244.87M | 4.71%934.51M | 2.59%239.78M | -0.80%224.86M |
Operating profit | 12.91%158.29M | 13.28%146.67M | 13.79%592.47M | 10.52%164.31M | 22.04%158.49M | 12.86%140.19M | 9.83%129.47M | 25.65%520.65M | 18.42%148.68M | 18.59%129.86M |
Net non-operating interest income (expenses) | 0 | 12.50%9K | 14.29%16K | 0 | 14.29%8K | 0 | 14.29%8K | -96.12%14K | 0 | 100.05%7K |
Non-operating interest income | --0 | 12.50%9K | 14.29%16K | --0 | 14.29%8K | --0 | 14.29%8K | -96.12%14K | --0 | 75.00%7K |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | 99.09%-2K | 0 | 0 | 98.64%-220K | 100.01%1K | -1,647.37%-294K | ||||
Income before tax | 12.49%157.7M | 13.28%146.68M | 13.84%592.48M | 10.52%164.31M | 22.32%158.5M | 12.78%140.19M | 9.83%129.48M | 30.58%520.44M | 18.41%148.68M | 35.88%129.58M |
Income tax | 11.50%48.76M | 13.84%45.36M | 13.69%183.09M | 10.44%50.52M | 21.96%49.01M | 13.51%43.73M | 8.88%39.84M | 44.23%161.04M | 71.98%45.74M | 37.07%40.18M |
Net income | 12.94%108.94M | 13.04%101.33M | 13.91%409.39M | 10.55%113.8M | 22.48%109.49M | 12.46%96.46M | 10.26%89.64M | 25.26%359.4M | 4.02%102.94M | 35.35%89.4M |
Net income continuous operations | 12.94%108.94M | 13.04%101.33M | 13.91%409.39M | 10.55%113.8M | 22.48%109.49M | 12.46%96.46M | 10.26%89.64M | 25.26%359.4M | 4.02%102.94M | 35.35%89.39M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 12.94%108.94M | 13.04%101.33M | 13.91%409.39M | 10.55%113.8M | 22.48%109.49M | 12.46%96.46M | 10.26%89.64M | 25.26%359.4M | 4.02%102.94M | 35.35%89.4M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 12.94%108.94M | 13.04%101.33M | 13.91%409.39M | 10.55%113.8M | 22.48%109.49M | 12.46%96.46M | 10.26%89.64M | 25.26%359.4M | 4.02%102.94M | 35.35%89.4M |
Gross dividend payment | ||||||||||
Basic earnings per share | 12.63%28.44 | 12.40%26.46 | 15.27%107.12 | 10.27%29.73 | 24.08%28.6 | 14.62%25.25 | 12.69%23.54 | 18.16%92.93 | 3.93%26.96 | 7.75%23.05 |
Diluted earnings per share | 12.60%28.4313 | 12.40%26.46 | 15.27%107.12 | 10.22%29.7146 | 24.08%28.6 | 14.62%25.25 | 12.69%23.54 | 18.16%92.93 | 6.05%26.96 | 35.85%23.05 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |